Alzheimer’s Association. 2021 Alzheimer’s disease facts and figures. Alzheimers Dement. 17, 327–406 (2021).
Reitz, C., Rogaeva, E. & Beecham, G. W. Late-onset vs nonmendelian early-onset Alzheimer disease: a distinction without a difference? Neurol. Genet. 6, e512 (2020).
PubMed PubMed Central Article Google Scholar
Ayodele, T., Rogaeva, E., Kurup, J. T., Beecham, G. & Reitz, C. Early-onset Alzheimer’s disease: what is missing in research? Curr. Neurol. Neurosci. Rep. 21, 4 (2021).
PubMed PubMed Central Article Google Scholar
Migliore, L. & Coppedè, F. Genetics, environmental factors and the emerging role of epigenetics in neurodegenerative diseases. Mutat. Res. 667, 82–97 (2009).
CAS PubMed Article Google Scholar
Jones, P. A. Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat. Rev. Genet. 13, 484–492 (2012).
CAS PubMed Article Google Scholar
Bannister, A. J. & Kouzarides, T. Regulation of chromatin by histone modifications. Cell Res. 21, 381–395 (2011).
CAS PubMed PubMed Central Article Google Scholar
Peschansky, V. J. & Wahlestedt, C. Non-coding RNAs as direct and indirect modulators of epigenetic regulation. Epigenetics 9, 3–12 (2014).
CAS PubMed Article Google Scholar
Jirtle, R. L. & Skinner, M. K. Environmental epigenomics and disease susceptibility. Nat. Rev. Genet. 8, 253–262 (2007).
CAS PubMed PubMed Central Article Google Scholar
Feil, R. & Fraga, M. F. Epigenetics and the environment: emerging patterns and implications. Nat. Rev. Genet. 13, 97–109 (2012).
CAS PubMed Article Google Scholar
Cavalli, G. & Heard, E. Advances in epigenetics link genetics to the environment and disease. Nature 571, 489–499 (2019).
CAS PubMed Article Google Scholar
van Dongen, J. et al. Genetic and environmental influences interact with age and sex in shaping the human methylome. Nat. Commun. 7, 11115 (2016).
PubMed PubMed Central Article Google Scholar
Perera, B., Faulk, C., Svoboda, L. K., Goodrich, J. M. & Dolinoy, D. C. The role of environmental exposures and the epigenome in health and disease. Environ. Mol. Mutagen. 61, 176–192 (2020).
CAS PubMed Article Google Scholar
Barker, D. J. The developmental origins of adult disease. Eur. J. Epidemiol. 18, 733–736 (2003).
CAS PubMed Article Google Scholar
Goate, A. et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer’s disease. Nature 349, 704–706 (1991).
CAS PubMed Article Google Scholar
Sherrington, R. et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer’s disease. Nature 375, 754–760 (1995).
CAS PubMed Article Google Scholar
Rogaev, E. I. et al. Familial Alzheimer’s disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer’s disease type 3 gene. Nature 376, 775–778 (1995).
CAS PubMed Article Google Scholar
Hardy, J. & Selkoe, D. J. The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 297, 353–356 (2002).
CAS PubMed Article Google Scholar
Cacace, R., Sleegers, K. & Van Broeckhoven, C. Molecular genetics of early‐onset Alzheimer’s disease revisited. Alzheimers Dement. 12, 733–748 (2016).
Strittmatter, W. J. et al. Apolipoprotein E: high-avidity binding to b-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl Acad. Sci. USA 90, 8098–8102 (1993).
CAS PubMed PubMed Central Article Google Scholar
Corder, E. H. et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science 261, 921–923 (1993).
CAS PubMed Article Google Scholar
Genin, E. et al. APOE and Alzheimer disease: a major gene with semi-dominant inheritance. Mol. Psychiatry 16, 903–907 (2011).
CAS PubMed PubMed Central Article Google Scholar
Yamazaki, Y., Zhao, N., Caulfield, T. R., Liu, C. C. & Bu, G. Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies. Nat. Rev. Neurol. 15, 501–518 (2019).
CAS PubMed PubMed Central Article Google Scholar
Harold, D. et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer’s disease. Nat. Genet. 41, 1088–1093 (2009).
CAS PubMed PubMed Central Article Google Scholar
Lambert, J. C. et al. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer’s disease. Nat. Genet. 41, 1094–1099 (2009).
CAS PubMed Article Google Scholar
Lambert, J. C. et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer’s disease. Nat. Genet. 45, 1452–1458 (2013).
CAS PubMed PubMed Central Article Google Scholar
Kunkle, B. et al. Meta-analysis of genetic association with diagnosed Alzheimer’s disease identifies novel risk loci and implicates Abeta, Tau, immunity and lipid processing. Nat. Genet. 51, 414–430 (2019).
CAS PubMed PubMed Central Article Google Scholar
Marioni, R. E. et al. GWAS on family history of Alzheimer’s disease. Transl. Psychiatry 8, 99 (2018).
PubMed PubMed Central Article Google Scholar
Jansen, I. E. et al. Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk. Nat. Genet. 51, 404–413 (2019).
CAS PubMed PubMed Central Article Google Scholar
Schwartzentruber, J. et al. Genome-wide meta-analysis, fine-mapping and integrative prioritization implicate new Alzheimer’s disease risk genes. Nat. Genet. 53, 392–402 (2021).
CAS PubMed PubMed Central Article Google Scholar
Wightman, D. P. et al. A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer’s disease. Nat. Genet. 53, 1276–1282 (2021).
CAS PubMed Article Google Scholar
Guerreiro, R. et al. TREM2 variants in Alzheimer’s disease. N. Engl. J. Med. 368, 117–127 (2013).
CAS PubMed Article Google Scholar
Bis, J. C. et al. Whole exome sequencing study identifies novel rare and common Alzheimer’s-associated variants involved in immune response and transcriptional regulation. Mol. Psychiatry 25, 1859–1875 (2020).
CAS PubMed Article Google Scholar
Sims, R., Hill, M. & Williams, J. The multiplex model of the genetics of Alzheimer’s disease. Nat. Neurosci. 23, 311–322 (2020).
CAS PubMed Article Google Scholar
Escott-Price, V. et al. Common polygenic variation enhances risk prediction for Alzheimer’s disease. Brain 138, 3673–3684 (2015).
PubMed PubMed Central Article Google Scholar
Escott-Price, V., Myers, A. J., Huentelman, M. & Hardy, J. Polygenic risk score analysis of pathologically confirmed Alzheimer disease. Ann. Neurol. 82, 311–314 (2017).
PubMed PubMed Central Article Google Scholar
Escott-Price, V. & Schmidt, K. M. Probability of Alzheimer’s disease based on common and rare genetic variants. Alzheimers Res. Ther. 13, 140 (2021).
CAS PubMed PubMed Central Article Google Scholar
Pyun, J. M. et al. Predictability of polygenic risk score for progression to dementia and its interaction with APOE epsilon4 in mild cognitive impairment. Transl. Neurodegener. 10, 32 (2021).
CAS PubMed PubMed Central Article Google Scholar
Ebenau, J. L. et al. Risk of dementia in APOE ε4 carriers is mitigated by a polygenic risk score. Alzheimers Dement. 13, e12229 (2021).
留言 (0)